NeuroFrontiers podcast

Investigating the Prevalence of Comorbidities in MS Clinical Trials

0:00
NaN:NaN:NaN
15 Sekunden vorwärts
15 Sekunden vorwärts
Host: Ashley Baker, MSN, PMHNP
Guest: Amber Salter, PhD

In 2016, an International Advisory Committee on Clinical Trials in Multiple Sclerosis (MS) recommended that comorbidities be more clearly and consistently described in enrolled clinical trial populations for common comorbidities so we can better understand the applicability of these trial findings to those in clinical practice. And so a recent study investigated the prevalence of comorbidities in MS clinical trial populations and found that 46 percent of the participants had one or more comorbid condition. Dive further into the findings from the study that was presented at the 2023 joint ECTRIMS-ACTRIMS meeting with Ashley Baker and Dr. Amber Salter, Associate Professor of Biostatistics at the University of Texas Southwestern Medical Center.

Weitere Episoden von „NeuroFrontiers“